OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis
Chris Lee, Evan S. Dellon
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 2, pp. 252-258
Closed Access | Times Cited: 32
Chris Lee, Evan S. Dellon
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 2, pp. 252-258
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 7
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 7
Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties
Laura Arias‐González, Leticia Rodríguez-Alcolado, Emilio J. Laserna‐Mendieta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 927-927
Open Access | Times Cited: 7
Laura Arias‐González, Leticia Rodríguez-Alcolado, Emilio J. Laserna‐Mendieta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 927-927
Open Access | Times Cited: 7
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7
Contribution of T cell subsets to different food allergic diseases
Lisa Hung, Brianna Zientara, M. Cecilia Berin
Immunological Reviews (2024) Vol. 326, Iss. 1, pp. 35-47
Open Access | Times Cited: 4
Lisa Hung, Brianna Zientara, M. Cecilia Berin
Immunological Reviews (2024) Vol. 326, Iss. 1, pp. 35-47
Open Access | Times Cited: 4
Modern Possibilities of Usage Dupilumab in Children
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
La esofagitis eosinofílica. Conceptos actuales de la fisiopatología, del diagnóstico y del tratamiento
Diego García‐Compeán, Alan Rafael Jiménez-Rodríguez, C.E. González-Martínez
Revista de Gastroenterología de México (2025)
Open Access
Diego García‐Compeán, Alan Rafael Jiménez-Rodríguez, C.E. González-Martínez
Revista de Gastroenterología de México (2025)
Open Access
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Interferon Signaling Alters Epithelial Function in Eosinophilic Esophagitis
Yash A. Choksi
Cellular and Molecular Gastroenterology and Hepatology (2025), pp. 101464-101464
Open Access
Yash A. Choksi
Cellular and Molecular Gastroenterology and Hepatology (2025), pp. 101464-101464
Open Access
Efficacy of Dupilumab in the Treatment of Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Szu-Hung Chu, Jeng-Jung Chen, Chung-Chu Chen, et al.
Life (2025) Vol. 15, Iss. 2, pp. 307-307
Open Access
Szu-Hung Chu, Jeng-Jung Chen, Chung-Chu Chen, et al.
Life (2025) Vol. 15, Iss. 2, pp. 307-307
Open Access
Real-world Effectiveness of Dupilumab in Eosinophilic Esophagitis
Archit Garg, Vishali Moond, Sugirdhana Velpari, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Archit Garg, Vishali Moond, Sugirdhana Velpari, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Treatment of eosinophilic esophagitis: literature review and own clinical observations
V. O. Kaybysheva, Е. Д. Федоров, Sergey Georgievich Shapovaliantc
Russian Journal of Allergy (2025)
Closed Access
V. O. Kaybysheva, Е. Д. Федоров, Sergey Georgievich Shapovaliantc
Russian Journal of Allergy (2025)
Closed Access
Frequent report of vitamin deficiencies and use of supplements and complementary/alternative treatment approaches in patients with eosinophilic gastrointestinal diseases
Brenderia A. Cameron, Elizabeth T. Jensen, Xiangfeng Dai, et al.
Therapeutic Advances in Rare Disease (2025) Vol. 6
Open Access
Brenderia A. Cameron, Elizabeth T. Jensen, Xiangfeng Dai, et al.
Therapeutic Advances in Rare Disease (2025) Vol. 6
Open Access
Eosinophilic esophagitis: Prevalence, diagnosis, and treatment in childhood and adulthood
André Hoerning, Jens-Oliver Steiß, Ahmed Madisch, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
André Hoerning, Jens-Oliver Steiß, Ahmed Madisch, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
Circulating Food Allergen‐Specific Antibodies, Beyond IgG4 , Are Elevated in Eosinophilic Esophagitis
Manal Bel Imam, Sayuri Iwasaki, Sophieke Lems, et al.
Clinical & Experimental Allergy (2025)
Closed Access
Manal Bel Imam, Sayuri Iwasaki, Sophieke Lems, et al.
Clinical & Experimental Allergy (2025)
Closed Access
Dupilumab in adolescent eosinophilic esophagitis: Experience with fibrostenosis and eosinophilic gastrointestinal disease with esophageal involvement
Robert E. Becker, Mariah Rigsby, Mariko Suchi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 78, Iss. 6, pp. 1337-1341
Closed Access | Times Cited: 3
Robert E. Becker, Mariah Rigsby, Mariko Suchi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 78, Iss. 6, pp. 1337-1341
Closed Access | Times Cited: 3
Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis
Jonathan M. Spergel, Mirna Chehade, Evan S. Dellon, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 3
Jonathan M. Spergel, Mirna Chehade, Evan S. Dellon, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 3
Advances and Ongoing Challenges in Eosinophilic Gastrointestinal Disorders presented at the CEGIR/TIGERS Symposium at the 2024 American Academy of Allergy, Asthma, & Immunology Meeting
Benjamin L. Wright, J. Pablo Abonia, Edsel M. Abud, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 4, pp. 882-892
Closed Access | Times Cited: 3
Benjamin L. Wright, J. Pablo Abonia, Edsel M. Abud, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 4, pp. 882-892
Closed Access | Times Cited: 3
Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment
Twan Sia, Amanda Miller, Leeon Bacchus, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Twan Sia, Amanda Miller, Leeon Bacchus, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Esophageal remodeling in eosinophilic esophagitis
Anisa Shaker
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 291-298
Open Access | Times Cited: 2
Anisa Shaker
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 291-298
Open Access | Times Cited: 2
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics
Salvatore Oliva, Seema S. Aceves, Noam Zevit, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1763-1769
Open Access | Times Cited: 2
Salvatore Oliva, Seema S. Aceves, Noam Zevit, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1763-1769
Open Access | Times Cited: 2
The role of dupilumab in the treatment of eosinophilic esophagitis
Erin Syverson, Eitan Rubinstein, John J. Lee, et al.
Immunotherapy (2024) Vol. 16, Iss. 13, pp. 845-852
Closed Access | Times Cited: 2
Erin Syverson, Eitan Rubinstein, John J. Lee, et al.
Immunotherapy (2024) Vol. 16, Iss. 13, pp. 845-852
Closed Access | Times Cited: 2
Real-world effectiveness and use of dupilumab in eosinophilic esophagitis
Michelle Russin, Joan W. Chen, Joel H. Rubenstein, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 2
Michelle Russin, Joan W. Chen, Joel H. Rubenstein, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 2
Dupilumab use in patients with hypereosinophilic syndromes: a multicenter case series and review of the literature
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Rodaba Rahim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Closed Access | Times Cited: 1
Ejiofor A.D. Ezekwe, Andrew L. Weskamp, Rodaba Rahim, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Closed Access | Times Cited: 1
Eosinophilic oesophagitis in adults: from symptoms to therapeutic options
Carlo Maria Rossi, Marco Vincenzo Lenti, Giovanni Santacroce, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 1
Carlo Maria Rossi, Marco Vincenzo Lenti, Giovanni Santacroce, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 1
